{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T13:54:31Z","timestamp":1790517271475,"version":"4.1.0"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2019,2,4]],"date-time":"2019-02-04T00:00:00Z","timestamp":1549238400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Ann Surg Oncol"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1245\/s10434-019-07209-x","type":"journal-article","created":{"date-parts":[[2019,2,4]],"date-time":"2019-02-04T15:01:22Z","timestamp":1549292482000},"page":"1358-1365","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Prognostic Value of Primary Tumor Sidedness for Unresectable Stage IV Colorectal Cancer: A Retrospective Study"],"prefix":"10.1245","volume":"26","author":[{"given":"Dai","family":"Shida","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taro","family":"Tanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narikazu","family":"Boku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsuo","family":"Takashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takefumi","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunsuke","family":"Tsukamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukihide","family":"Kanemitsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,2,4]]},"reference":[{"key":"7209_CR1","volume-title":"TNM classification of malignant tumours","author":"UICC","year":"2017","unstructured":"UICC. TNM classification of malignant tumours. 8th ed. New York: Wiley; 2017.","edition":"8"},{"issue":"12","key":"7209_CR2","doi-asserted-by":"publisher","first-page":"2091","DOI":"10.1200\/JCO.2009.21.9170","volume":"27","author":"CJ Allegra","year":"2009","unstructured":"Allegra CJ, Jessup JM, Somerfield MR, et al. American society of clinical oncology provisional clinical opinion: testing for KRAS gene mutations in patients with metastatic colorectal carcinoma to predict response to anti-epidermal growth factor receptor monoclonal antibody therapy. J Clin Oncol. 2009;27(12):2091\u20136.","journal-title":"J Clin Oncol"},{"issue":"1","key":"7209_CR3","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1053\/j.gastro.2014.09.041","volume":"148","author":"FA Sinicrope","year":"2015","unstructured":"Sinicrope FA, Shi Q, Smyrk TC, et al. Molecular markers identify subtypes of stage III colon cancer associated with patient outcomes. Gastroenterology. 2015;148(1):88\u201399.","journal-title":"Gastroenterology."},{"issue":"23","key":"7209_CR4","doi-asserted-by":"publisher","first-page":"6531","DOI":"10.1158\/1078-0432.CCR-12-0605","volume":"18","author":"PG Gavin","year":"2012","unstructured":"Gavin PG, Colangelo LH, Fumagalli D, et al. Mutation profiling and microsatellite instability in stage II and III colon cancer: an assessment of their prognostic and oxaliplatin predictive value. Clin Cancer Res. 2012;18(23):6531\u201341.","journal-title":"Clin Cancer Res"},{"issue":"3","key":"7209_CR5","doi-asserted-by":"publisher","first-page":"411","DOI":"10.6004\/jnccn.2017.0038","volume":"15","author":"MS Lee","year":"2017","unstructured":"Lee MS, Menter DG, Kopetz S. Right versus left colon cancer biology: integrating the consensus molecular subtypes. J Natl Compr Cancer Netw. 2017;15(3):411\u20139.","journal-title":"J Natl Compr Cancer Netw"},{"issue":"8","key":"7209_CR6","doi-asserted-by":"publisher","first-page":"1713","DOI":"10.1093\/annonc\/mdx175","volume":"28","author":"D Arnold","year":"2017","unstructured":"Arnold D, Lueza B, Douillard JY, et al. Prognostic and predictive value of primary tumour side in patients with RAS wild-type metastatic colorectal cancer treated with chemotherapy and EGFR directed antibodies in six randomized trials. Ann Oncol. 2017;28(8):1713\u201329.","journal-title":"Ann Oncol"},{"key":"7209_CR7","doi-asserted-by":"publisher","unstructured":"Tejpar S, Stintzing S, Ciardiello F, et al. prognostic and predictive relevance of primary tumor location in patients with RAS wild-type metastatic colorectal cancer: Retrospective analyses of the CRYSTAL and FIRE-3 Trials. JAMA Oncol. Epub 10 Oct 2016. \n                    https:\/\/doi.org\/10.1001\/jamaoncol.2016.3797\n                    \n                  .","DOI":"10.1001\/jamaoncol.2016.3797"},{"key":"7209_CR8","doi-asserted-by":"crossref","unstructured":"Loupakis F, Yang D, Yau L, et al. Primary tumor location as a prognostic factor in metastatic colorectal cancer. J Natl Cancer Inst. 2015;107(3): pii: dju427.","DOI":"10.1093\/jnci\/dju427"},{"issue":"1","key":"7209_CR9","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1245\/s10434-017-6133-7","volume":"25","author":"D Shida","year":"2018","unstructured":"Shida D, Tsukamoto S, Ochiai H, Kanemitsu Y. long-term outcomes after R0 resection of synchronous peritoneal metastasis from colorectal cancer without cytoreductive surgery or hyperthermic intraperitoneal chemotherapy. Ann Surg Oncol. 2018;25(1):173\u20138.","journal-title":"Ann Surg Oncol"},{"issue":"6","key":"7209_CR10","doi-asserted-by":"publisher","first-page":"1646","DOI":"10.1245\/s10434-018-6436-3","volume":"25","author":"D Shida","year":"2018","unstructured":"Shida D, Yoshida T, Tanabe T, Tsukamoto S, Ochiai H, Kanemitsu Y. Prognostic impact of R0 resection and targeted therapy for colorectal cancer with synchronous peritoneal metastasis. Ann Surg Oncol. 2018;25(6):1646\u201353.","journal-title":"Ann Surg Oncol"},{"issue":"4","key":"7209_CR11","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.clcc.2012.05.005","volume":"11","author":"TH Cartwright","year":"2012","unstructured":"Cartwright TH, Yim YM, Yu E, Chung H, Halm M, Forsyth M. Survival outcomes of bevacizumab beyond progression in metastatic colorectal cancer patients treated in US community oncology. Clin Colorectal Cancer. 2012;11(4):238\u201346.","journal-title":"Clin Colorectal Cancer"},{"issue":"11","key":"7209_CR12","doi-asserted-by":"publisher","first-page":"3602","DOI":"10.1245\/s10434-016-5299-8","volume":"23","author":"D Shida","year":"2016","unstructured":"Shida D, Hamaguchi T, Ochiai H, et al. Prognostic impact of palliative primary tumor resection for unresectable stage 4 colorectal cancer: using a propensity score analysis. Ann Surg Oncol. 2016;23(11):3602\u20138.","journal-title":"Ann Surg Oncol"},{"issue":"7","key":"7209_CR13","doi-asserted-by":"publisher","first-page":"1025","DOI":"10.1016\/j.ejso.2018.03.022","volume":"44","author":"D Shida","year":"2018","unstructured":"Shida D, Ochiai H, Tsukamoto S, Kanemitsu Y. Long-term outcomes of laparoscopic versus open D3 dissection for stage II\/III colon cancer: results of propensity score analyses. Eur J Surg Oncol. 2018;44(7):1025\u201330.","journal-title":"Eur J Surg Oncol"},{"issue":"4","key":"7209_CR14","doi-asserted-by":"publisher","first-page":"406","DOI":"10.1016\/j.molonc.2007.12.001","volume":"1","author":"GM Clark","year":"2008","unstructured":"Clark GM. Prognostic factors versus predictive factors: examples from a clinical trial of erlotinib. Mol Oncol. 2008;1(4):406-12.","journal-title":"Mol Oncol"},{"issue":"3","key":"7209_CR15","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.clcc.2016.11.006","volume":"16","author":"K Wallace","year":"2017","unstructured":"Wallace K, DeToma A, Lewin DN, et al. Racial differences in stage IV colorectal cancer survival in younger and older patients. Clin Colorectal Cancer. 2017;16(3):178\u201386.","journal-title":"Clin Colorectal Cancer"},{"issue":"4","key":"7209_CR16","doi-asserted-by":"publisher","first-page":"e221","DOI":"10.1016\/j.clcc.2016.03.001","volume":"15","author":"M Shabihkhani","year":"2016","unstructured":"Shabihkhani M, Yu SS, Yang D, et al. Metastatic colorectal cancer in hispanics: treatment outcomes in a treated population. Clin Colorectal Cancer. 2016;15(4):e221\u20137.","journal-title":"Clin Colorectal Cancer"},{"issue":"1","key":"7209_CR17","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1186\/s12885-018-4241-9","volume":"18","author":"D Shida","year":"2018","unstructured":"Shida D, Ahiko Y, Tanabe T, et al. Shorter survival in adolescent and young adult patients, compared to adult patients, with stage IV colorectal cancer in Japan. BMC Cancer. 2018;18(1):334.","journal-title":"BMC Cancer"},{"issue":"6","key":"7209_CR18","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1007\/s00268-004-7306-7","volume":"28","author":"JB O\u2019Connell","year":"2004","unstructured":"O\u2019Connell JB, Maggard MA, Liu JH, Etzioni DA, Livingston EH, Ko CY. Do young colon cancer patients have worse outcomes? World J Surg. 2004;28(6):558\u201362.","journal-title":"World J Surg."},{"issue":"2","key":"7209_CR19","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1007\/s00384-006-0093-x","volume":"22","author":"C Azzoni","year":"2007","unstructured":"Azzoni C, Bottarelli L, Campanini N, et al. Distinct molecular patterns based on proximal and distal sporadic colorectal cancer: arguments for different mechanisms in the tumorigenesis. Int J Colorectal Dis. 2007;22(2):115\u201326.","journal-title":"Int J Colorectal Dis"},{"issue":"11","key":"7209_CR20","doi-asserted-by":"publisher","first-page":"1350","DOI":"10.1038\/nm.3967","volume":"21","author":"J Guinney","year":"2015","unstructured":"Guinney J, Dienstmann R, Wang X, et al. The consensus molecular subtypes of colorectal cancer. Nat Med. 2015;21(11):1350\u20136.","journal-title":"Nat Med"},{"issue":"1","key":"7209_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10147-017-1101-6","volume":"23","author":"T Watanabe","year":"2018","unstructured":"Watanabe T, Muro K, Ajioka Y, et al. Japanese society for cancer of the colon and rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancer. Int J Clin Oncol. 2018;23(1):1\u201334.","journal-title":"Int J Clin Oncol"}],"container-title":["Annals of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1245\/s10434-019-07209-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-019-07209-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1245\/s10434-019-07209-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,3]],"date-time":"2020-02-03T19:06:43Z","timestamp":1580756803000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1245\/s10434-019-07209-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,4]]},"references-count":21,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["7209"],"URL":"https:\/\/doi.org\/10.1245\/s10434-019-07209-x","relation":{},"ISSN":["1068-9265","1534-4681"],"issn-type":[{"value":"1068-9265","type":"print"},{"value":"1534-4681","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,4]]},"assertion":[{"value":"17 August 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2019","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors have no commercial interests to report.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Commercial Interests"}},{"value":"Dai Shida, Taro Tanabe, Narikazu Boku, Atsuo Takashima, Takefumi Yoshida, Shunsuke Tsukamoto, and Yukihide Kanemitsu have no conflict of interest to report.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}